Use of the UK General Practice Research Database for pharmacoepidemiology

British Journal of Clinical Pharmacology
L A García Rodríguez, S Pérez Gutthann

Abstract

The last decade has seen a surge in the use of computerized health care data for pharmacoepidemiology. Of all European databases, the General Practice Research Database (GPRD) in the UK, has been the most widely used for pharmacoepidemiological research. Since 1994, this database has belonged to the UK Department of Health, and is maintained by the Office of National Statistics (ONS). Currently, around 1500 general practitioners with a population coverage in excess of 3 million, systematically provide their computerized medical data anonymously to ONS. Validation studies of the GPRD have documented the recording of medical data into general practitioners' computers to be near to complete. The GPRD collects truly population-based data, has a size that makes it possible to follow-up large cohorts of users of specific drugs, and includes both outpatient and inpatient clinical information. The access to original medical records is excellent. Desirable improvements to the GPRD would be additional computerized information on certain variables and linkage to other health care databases. Most published studies to date have been in the area of drug safety. The General Practice Research Database has proved that valuable data can be colle...Continue Reading

References

Jan 1, 1978·American Journal of Epidemiology·H Jick, M P Vessey
Apr 1, 1992·Journal of Epidemiology and Community Health·R M HeringsG Nap
Apr 1, 1991·Statistics in Medicine·B L StromW S Dai
Apr 1, 1989·American Journal of Epidemiology·W A Ray, M R Griffin
Mar 1, 1984·Pharmacotherapy·H JickA Stergachis
Feb 22, 1997·Lancet·H JickC R Meier
Mar 15, 1997·BMJ : British Medical Journal·S Pérez GutthannA Duque Oliart
May 1, 1997·Hypertension·J H OlsenJ Olsen
Apr 23, 1999·Lancet·T Walley, A Mantgani

❮ Previous
Next ❯

Citations

Jul 23, 1999·Pharmacotherapy·S Pérez-GutthannC Varas-Lorenzo
Jul 25, 2000·British Journal of Clinical Pharmacology·F J de AbajoS Schmitz
Nov 9, 2000·British Journal of Clinical Pharmacology·A D McMahon, T M MacDonald
May 10, 2002·Pharmacoepidemiology and Drug Safety·Consuelo HuertaSaga Johansson
Mar 11, 2004·BJOG : an International Journal of Obstetrics and Gynaecology·S E BromleyR D T Farmer
Oct 27, 2004·Journal of Neurology·Miguel A HernánLuis A García Rodríguez
Nov 24, 2004·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Raymond G SchliengerChristoph R Meier
Sep 24, 2004·Alimentary Pharmacology & Therapeutics·A RuigómezJ Dent
Sep 21, 2004·Breast Cancer Research and Treatment·Brian D BradburySusan S Jick
Aug 6, 2005·American Journal of Respiratory and Critical Care Medicine·Jonathan M Samet
May 20, 2005·American Journal of Respiratory and Critical Care Medicine·Victor A KiriJørgen Vestbo
Jun 28, 2005·Pharmacotherapy·Lorenz M FischerChristoph R Meier
Sep 27, 2005·Cancer Causes & Control : CCC·A González-Pérez, L A García Rodríguez
Jul 13, 2005·BMC Cardiovascular Disorders·Ana RuigómezLuis Alberto García Rodríguez
Jan 6, 2006·The American Journal of Gastroenterology·Radhika SrinivasanJames D Lewis
Oct 27, 2006·Pharmacoepidemiology and Drug Safety·James D LewisBrian L Strom
Sep 2, 2006·Menopause : the Journal of the North American Menopause Society·Alejandro AranaLuis A García Rodríguez
Jan 2, 2009·Scandinavian Journal of Rheumatology·L A García RodríguezM-A Wallander
Jan 29, 2009·Pharmacoepidemiology and Drug Safety·Lyn ColvinCarol Bower
Nov 13, 2009·Climacteric : the Journal of the International Menopause Society·C SchneiderC R Meier
Feb 18, 2010·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Saga JohanssonLuis Alberto García Rodríguez
Mar 8, 2011·Birth Defects Research. Part A, Clinical and Molecular Teratology·Lyn ColvinCarol Bower
May 9, 2012·Respirology : Official Journal of the Asian Pacific Society of Respirology·Rajeev K AmarChristoph R Meier
Feb 5, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Preciosa M ColomaMiriam Sturkenboom
Apr 5, 2013·Pharmacotherapy·Catherine Vasilakis-ScaramozzaSusan S Jick
Sep 1, 2008·Expert Review of Clinical Pharmacology·Peter Ian Pillans
Jan 5, 2014·Cancer Causes & Control : CCC·Leah BensimonLaurent Azoulay
Nov 28, 2014·Journal of Clinical Pharmacology·Franco LapiSamy Suissa
May 15, 2015·International Journal of Obesity : Journal of the International Association for the Study of Obesity·J F HayesI Douglas
Nov 27, 2014·Pharmacoepidemiology and Drug Safety·Elizabeth M KangAdel Abou-Ali

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.